Ana Alcaraz

2.2k citations
32 papers · 1.5k indexed · h-index 15
Topics
Virus-based gene therapy research (3 papers)Toxoplasma gondii Research Studies (3 papers)Microbial infections and disease research (3 papers)
Partner nations
United StatesSpainFrance

In The Last Decade

Ana Alcaraz

30 papers receiving 1.4k citations

Peers

Ana Alcaraz
Comparison fields: 5 of 97
  • Molecular Biology 603
  • Epidemiology 296
  • Cell Biology 250
  • Immunology 209
  • Immunology and Allergy 203
Replace Ron Peek with:
Ron Peek Netherlands
Christopher E. Andoniou Australia
Rebecca I. Montgomery United States
Nancy Sawtell United States
Patrick M. Stuart United States
F. Murata United States
Marco De Andrea Italy
John E. Oakes United States
Tatiana Gianni Italy
T Nakagawa United States
Ana Alcaraz relative to Ron Peek Netherlands Ron Peek's profile →
Citations per field
00.5×5.8×
Ron Peek · 1×
Citations per year

Countries citing papers authored by Ana Alcaraz

Since Specialization
Citations

This map shows the geographic impact of Ana Alcaraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Alcaraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Alcaraz more than expected).

Fields of papers citing papers by Ana Alcaraz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Alcaraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Alcaraz. The network helps show where Ana Alcaraz may publish in the future.

Co-authorship network of co-authors of Ana Alcaraz

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Alcaraz. A scholar is included among the top collaborators of Ana Alcaraz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Alcaraz. Ana Alcaraz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 2
3 44
4 9
5 53
6 6
7 75
8 11
9 4
10 20
11 104
12 98
13 29
14 238
15 4
16 7
17 15
18 6
19 31
20 51

About Ana Alcaraz

Ana Alcaraz is a scholar working on Equine, Parasitology and Immunology and Allergy, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), Toxoplasma gondii Research Studies (3 papers) and Microbial infections and disease research (3 papers). The work is most often cited by research in Immunology and Allergy (203 citations), Parasitology (187 citations) and Cell Biology (250 citations). Ana Alcaraz has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Jun‐Lin Guan, Susan K. Bliss, Eric Denkers, Xu Peng, Tamás Nagy, L. Cristina Gavrilescu, Hua Gu, Peng Xu, Boyi Gan and Richard A. Flavell. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026